Last reviewed · How we verify
NCT07172633
Effects of Dementia Scenario-Based Simulation Teaching Combined With Virtual Technology Among Nursing Students
NA trial testing scenario-based simulation teaching with virtual technology in Dementia Simulation-based Teaching in 50 participants. Currently enrolling.
31 January 2026
Quick facts
| Lead sponsor | Huei-Chuan Sung |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 50 |
| Start date | 10 September 2025 |
| Primary completion | 31 January 2026 |
| Estimated completion | 31 July 2026 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- scenario-based simulation teaching with virtual technology
- traditional dementia case discussions
Conditions studied
- Dementia Simulation-based Teaching — all drugs for Dementia Simulation-based Teaching →
Sponsor
Huei-Chuan Sung
Who can join
Adults 18 to 40, any sex, with Dementia Simulation-based Teaching. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to evaluate the effects of scenario-based simulation teaching with virtual technology on dementia knowledge, empathy, communication, and assessment skills among nursing students.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07172633
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07172633 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Huei-Chuan Sung
- Last refreshed: 18 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07172633.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing